Jul 23, 2026 07:12AM
Jul 21, 2026 08:32AM
Jul 21, 2026 08:30AM
Jun 25, 2026 11:35AM
Jun 25, 2026 11:35AM
Jun 15, 2026 06:51AM
May 28, 2026 03:43AM Barclays Starts Alpha Tau Medical Ltd. (DRTS) at Overweight
May 20, 2026 06:47AM
May 18, 2026 04:01PM
May 12, 2026 06:52AM
May 11, 2026 07:01AM
May 11, 2026 07:00AM
May 8, 2026 09:00AM
May 8, 2026 09:00AM Alpha Tau Completes Patient Enrollment in its U.S. Pivotal Skin Cancer Study, Advancing Towards Goal of FDA Approval of Alpha DaRT® to Treat Recurrent Cutaneous Squamous Cell Carcinoma
Apr 27, 2026 06:49AM
Apr 23, 2026 09:02AM
Apr 23, 2026 09:02AM
Mar 9, 2026 04:02PM
Jan 6, 2026 06:45AM
Nov 20, 2025 04:05PM
Aug 11, 2025 04:02PM Alpha Tau Announces Second Quarter 2025 Financial Results and Provides Corporate Update
May 19, 2025 04:01PM
Mar 18, 2025 06:43AM
Mar 12, 2025 04:02PM
Jan 27, 2025 09:00AM
Nov 19, 2024 04:00PM
Oct 21, 2024 08:32AM
Oct 21, 2024 08:30AM Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma Multiforme
Aug 15, 2024 08:46AM
Mar 7, 2024 04:01PM
Nov 16, 2023 04:30PM
Mar 8, 2023 05:00PM
Sep 8, 2022 04:05PM
Aug 25, 2022 04:05PM
Jun 8, 2022 09:10AM Alpha Tau Medical (DRTS) Announces FDA Approval of IDE to Initiate Multi-Center Pivotal Study of Alpha DaRT in Recurrent Cutaneous SCC
Jun 8, 2022 09:10AM
Apr 4, 2022 05:31AM
Mar 28, 2022 08:00AM

327,814 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All